Diabetes Drugs Latest to Be Targeted for Carcinogen Scr...
(Bloomberg) Dec 4, 2019 - Global health regulators are looking into whether widely used diabetes drugs may contain unsafe levels of a carcinog...
Lilly Puts Its Cancer Future In Loxo's Hands
(BioPharma Dive) Dec 5, 2019 - Eli Lilly is turning to executives from Loxo Oncology, the biotech it bought in January for $8 billion, to lead...
Michael J. Birrer, MD, PhD, elaborates on the outcomes from the FORWARD I study
Joyce O’Shaughnessy, MD, shares relevant findings from the MONARCH-2 trial
November 2019 Edition
Patient-reported outcomes (PROs) monitoring has been shown to have multiple benefits for cancer patients, while also representing an important tool for providers in implementing value-bas...
November 2019 Edition
Artificial intelligence (AI) has the potential to identify patients with cancer at high risk of unplanned utilization of acute care, a critical healthcare cost driver. OBR spoke with Card...
What to Look for at ASH 2019Nov 26, 2019
During a pre-meeting webinar devoted to ASH 2019, experts highlighted important advances and practice-changing studies to be presented in Orlando, FL, December 7-...
Third-Line Treatment in Metastatic Colorectal Cancer Po...Oct 07, 2019
Targeted oral tyrosine kinase inhibitors (TKIs) have an established role in third-line treatment of metastatic colorectal cancer (mCRC), but an expert outlined an...
ESMO Opens with Survival Benefits from Long-Term Data i...Sep 30, 2019
The 2019 European Society of Medical Oncology (ESMO) opened with a series of trials with positive overall survival (OS) data. Generally considered the gold standa...
Stemming from the user preference that you set, stay informed and increase your productivity via 27/7 web based access to Ontellitrac and a customized email alert system summarizing the most recent oncology-specific information available.Learn More
The Oncology Business Dynamics Learning Platform addresses the need to have a high level of understanding of the non-clinical issues that are influencing the decision making process for hem/oncs today.Learn More
San Antonio, TX
San Francisco, CA
New Orleans, LA
St. Gallen, Switzerland
San Diego, CA
|Date||Company and Product|
Celgene / bluebird bio,
Celgene / Bluebird Bio,